Ann: Further information - Strategic Partnership Rewards Platform, page-2

Hmmm, more waffle, but its in depth now..

TCG

Further information regarding Strategic Partnership – US employee rewards platform
HeraMED Limited (ASX:HMD) (“HeraMED” or the “Company”, a medical data and technology company
leading the digital transformation of maternity care, provides further information in relation to its
announcement made on 1 June 2023 titled ‘Strategic Partnership signed – US employee rewards platform’.
HeraMED is not able to provide specific financial information or forecasts in relation to the Strategic
Partnership. Whilst Fond and Entrustia Health will proactively promote and market the HeraCARE solution to
its customers, HeraMED can’t guarantee that material revenue will arise as it depends on the customer
uptake. HeraMED will update the market regularly with key measures of success related to this Strategic
Partnership, in its Quarterly reviews.

The Fond agreement:
• is not subject to any condition’s precedent; and
• has an initial term of 12 months and shall automatically renew for each successive month unless
one party provides written notice to the other at least thirty (30) days in advance that it does not
wish to renew the following month.

The Entrustia agreement:
• is not subject to any condition’s precedent; and
• has an initial term of three years to 16 May 2026 and the agreement shall automatically extend for
subsequent terms of 12 months unless HeraMED wishes to terminate the agreement by written
notice within 30 days of the expiry of the initial term or any subsequent term.

The Strategic Partnership in detail
HeraMED has signed a Strategic Partnership with Fond, a global SaaS platform that consolidates employee
rewards and recognition processes into an easy-to-use solution. Fond was approached by one of their
corporate customers requesting HeraCARE be added to the Fond platform as a way for them to provide
improved maternity care for their employees and their family members. This initial Fond customer is a
California-based, global social media company with over 7,000 employees and the program is scheduled to
go live in the coming weeks. The HeraMED solution will be offered to all employees, and it will also be
extended to their partners and up to five family members.

The intention of this enterprise agreement is to allow Fond to add HeraCARE to all the employees of their
corporate customers including partners and family members. Each Corporate client may choose to subsidise
the cost of the HeraCARE solution in part or in full. Government funded reimbursements and tax deductions
may also be available depending on the unique financial situation of the employee.

In addition to the Fond enterprise agreement, HeraMED entered into an agreement with Entrustia Health, to
provide Obstetrics and Gynaecology support to those pregnant women using HeraCARE through the Fond
agreement. Entrustia Health’s obstetricians and clinicians will be responsible for coordinating the
implementation and provision of care support.